HeartWare International Inc. said it would price the public offering of more than 1.5 million shares at $35.50 per share.
The Framingham-based medical device company announced the offering of 1.5 million shares Wednesday. Now, the company said it will offer 1.54 million shares with underwriters holding an option to purchase an additional 230,595 shares.
The company said it would use the proceeds of the sale for general corporate purposes and as working capital. The sale is being run by J.P. Morgan Securities Inc.
HeartWare filed a shelf registration for the sale with the U.S. Securities and Exchange Commission in December.
For the third quarter, the company reported $31 million in cash and equivalents, $7.5 million in revenue and a $5.9 million loss.
